FY2025 · period end Dec '25 · from the 10-K filed Feb 6, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $199.13B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001156039-26-000049 | Jun 10, 2026 | Jun 10, 2026 | Jun 10, 2026 10:01 UTC | EDGAR |
| 8-K | 0001156039-26-000046 | May 13, 2026 | May 13, 2026 | May 13, 2026 20:07 UTC | EDGAR |
| 8-K | 0001156039-26-000039 | Apr 22, 2026 | Apr 22, 2026 | Apr 22, 2026 10:02 UTC | EDGAR |
| 10-Q | 0001156039-26-000043 | Mar 31, 2026 | Apr 22, 2026 | Apr 22, 2026 14:09 UTC | EDGAR |
| 8-K | 0001156039-26-000024 | Mar 10, 2026 | Mar 10, 2026 | Mar 10, 2026 10:02 UTC | EDGAR |
| 8-K | 0001156039-26-000022 | Mar 2, 2026 | Mar 2, 2026 | Mar 2, 2026 11:03 UTC | EDGAR |
| 8-K | 0001156039-26-000019 | Feb 26, 2026 | Feb 26, 2026 | Feb 26, 2026 19:59 UTC | EDGAR |
| 10-K | 0001156039-26-000013 | Dec 31, 2025 | Feb 6, 2026 | Feb 6, 2026 19:57 UTC | EDGAR |
Direct links to SEC EDGAR. ELV has additional filings available on the SEC site.
Who is buying and selling Elevance Health, Inc. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on ELV yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on ELV and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $171.34B |
| $156.59B |
| $138.64B |
| Gross Profit | $177.95B | $157.26B | $154.05B | $143.56B | $127.74B |
|---|
| Operating Income | $7.20B | $7.86B | $8.50B | $8.28B | $7.56B |
|---|
| Net Income | $5.66B | $5.98B | $5.99B | $5.89B | $6.16B |
|---|
| EPS (Diluted) | $25.21 | $25.68 | $25.22 | $24.28 | $24.95 |
|---|
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $121.49B | $116.89B | $108.93B | $102.75B | $97.46B |
| Total Liabilities | $77.47B | $75.46B | $69.52B | $66.42B | $61.29B |
| Stockholders' Equity | $44.03B | $41.43B | $39.41B | $36.33B | $36.14B |
| Cash & Equivalents | $9.49B | $8.29B | $6.53B | $7.39B | $4.88B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $4.29B | $5.81B | $8.06B | $8.40B | $8.36B |
| Capital Expenditures | $1.12B | $1.26B | $1.30B | $1.15B | $1.09B |
| Free Cash Flow | $3.17B | $4.55B | $6.76B | $7.25B | $7.28B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 89.4% | 88.8% | 89.9% | 91.7% | 92.1% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.1% | 0.1% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Return on Equity | 13.3% | 14.8% | 15.8% | 16.3% | 17.8% |
| Return on Assets | 4.8% | 5.3% | 5.7% | 5.9% | 6.7% |
| Debt / Equity | 0.75× | 0.79× | 0.68× | 0.71× | 0.68× |
